Slough, United Kingdom

Tracy Lynn Arakaki


 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Slough Berkshire, GB (2020)
  • Slough, GB (2021 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tracy Lynn Arakaki: Innovator in Anti-TNFα Antibodies

Introduction

Tracy Lynn Arakaki is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of anti-TNFα antibodies. With a total of 4 patents to her name, her work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

One of her latest patents is focused on methods of use of anti-TNFα antibodies. This patent demonstrates that certain compounds can bind to TNF and stabilize a conformation of trimeric TNF that binds to the TNF receptor. The antibodies disclosed in this patent selectively bind to complexes of such compounds with TNF superfamily members. These antibodies may be utilized to detect further compounds with similar activity and serve as target engagement biomarkers.

Another significant patent involves a method of identifying potential inhibitors of APO TNFα trimers. This patent reveals a new, stable trimeric TNFα structure with distorted symmetry that can bind to the TNFR1 receptor, attenuating signaling. This innovation can be used in the treatment and prevention of diseases associated with the soluble TNFα/TNFR1 interaction. Importantly, membrane-bound TNFα retains its ability to signal through TNFR2, allowing for therapies that do not significantly increase the risk of infection or malignancy.

Career Highlights

Throughout her career, Tracy has worked with notable companies such as UCB Biopharma and Sanofi. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.

Collaborations

Tracy has collaborated with esteemed colleagues, including James Philip O'Connell and John Robert Porter. These partnerships have further enriched her research and innovation efforts.

Conclusion

Tracy Lynn Arakaki is a trailblazer in the field of anti-TNFα antibodies, with a strong portfolio of patents that showcase her innovative spirit. Her work continues to pave the way for advancements in therapeutic solutions for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…